SBRA:NGS-Sabra Healthcare REIT Inc. (USD)

EQUITY | REIT - Healthcare Facilities | Nasdaq Global Select

Last Closing

USD 17.48

Change

0.00 (0.00)%

Market Cap

USD 1.42B

Volume

2.22M

Analyst Target

USD 14.65
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Sabra Health Care REIT Inc operates as a self-administered & self-managed REIT. The Company through its subsidiaries is engaged in acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
DHC Diversified Healthcare Trust

+0.06 (+1.90%)

USD 0.73B
NHPAP National Healthcare Properties..

N/A

N/A
NHPBP National Healthcare Properties..

-0.23 (-1.71%)

N/A

ETFs Containing SBRA

BYRE Principal Exchange-Traded.. 4.59 % 0.00 %

-0.13 (0.47%)

USD 0.01B
KBWY Invesco KBW Premium Yield.. 3.89 % 0.35 %

+0.09 (+0.47%)

USD 0.21B
RIET Hoya Capital High Dividen.. 1.63 % 0.00 %

+0.07 (+0.47%)

USD 0.09B
DES WisdomTree U.S. SmallCap .. 1.22 % 0.38 %

+0.42 (+0.47%)

USD 1.83B
GRI GRI Bio Inc. 0.00 % 0.55 %

+0.07 (+0.47%)

N/A
HIPS GraniteShares HIPS US Hig.. 0.00 % 0.70 %

+0.12 (+0.47%)

N/A
XMMD:LSE Xtrackers - MSCI Emerging.. 0.00 % 0.00 %

+0.30 (+0.47%)

N/A
SDIV:LSE Global X SuperDividend UC.. 0.00 % 0.00 %

+0.04 (+0.47%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.92% 50% F 64% D
Dividend Return 1.73% 100% F 72% C
Total Return 2.66% 50% F 69% C-
Trailing 12 Months  
Capital Gain 19.89% 50% F 77% C+
Dividend Return 6.17% 100% F 88% B+
Total Return 26.06% 50% F 80% B-
Trailing 5 Years  
Capital Gain 22.58% 100% F 57% F
Dividend Return 39.97% 100% F 90% A-
Total Return 62.55% 100% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 3.35% 50% F 54% F
Dividend Return 11.07% 50% F 67% D+
Total Return 7.72% 100% F 95% A
Risk Return Profile  
Volatility (Standard Deviation) 21.19% 100% F 74% C
Risk Adjusted Return 52.25% 100% F 81% B-
Market Capitalization 1.42B 100% F 87% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.80 50% 31%
Price/Book Ratio 1.60 50% 53%
Price / Cash Flow Ratio 13.94 50% 21%
Price/Free Cash Flow Ratio 15.79 50% 24%
Management Effectiveness  
Return on Equity 5.15% 100% 67%
Return on Invested Capital 4.94% 100% 66%
Return on Assets 3.14% 100% 77%
Debt to Equity Ratio 84.31% 100% 25%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector